Occlutech Holding AG
SCHAFFHAUSEN, SWITZERLAND / ACCESSWIRE / December 21, 2021 / Occlutech Holding AG
Occlutech Holding AG ("Occlutech" or the "Company"), a leading specialist provider of minimally invasive structural heart disease devices, addressing congenital heart defects, stroke prevention and heart failure, has successfully completed a private placement of shares (the "Private Placement") of 450 MSEK before transaction costs, to the Fourth Swedish National Pension Fund, Carnegie Private Banking and certain other investors. The purpose of the issue is to support Occlutech's significant opportunities in the U.S. market, continue to facilitate Occlutech's growth, as well as to repay maturing loans.
Occlutech has completed a Private Placement corresponding to SEK 450 million before transaction costs to finance the Company's growth ambition. The Private Placement attracted a lot of interest and was led by the Fourth Swedish National Pension Fund and Carnegie Private Banking.
Occlutech sells its products in over 85 countries, whereby the European market is dominant with a strong market share. The Company has a clear growth strategy, both in existing markets as well as through further global expansion. In particular, the U.S. market is expected to have significant growth opportunities for Occlutech's products and is therefore considered a future key market.
Earlier this year Occlutech set up a subsidiary in the U.S., focusing on clinical, regulatory, logistics, and supporting distribution. The Company also received granted conditional approval from the U.S. Food and Drug Administration (FDA) for IDE applications to conduct a pivotal Patent Foramen Ovale (PFO) study for Occlutech's PFO Occluder and a pivotal study for Occlutech's Atrial Flow Regulator (AFR) device for heart failure. The Company anticipates receiving an FDA market approval for the U.S. in 2026.
"Occlutech's sales continue to progress with good momentum, confirming the quality and competitiveness of the company's products. The U.S. market represents a significant growth potential for Occlutech and the financial strength that comes from the Private Placement allows Occlutech to continue with clinical trials for regulatory approvals in the U.S. for both the AFR device for heart failure and the PFO Occluder for stroke prevention", says Sabine Bois, CEO of Occlutech.
"Occlutech's Board welcomes the Fourth Swedish National Pension Fund and Carnegie Private Banking, together with other investors as new shareholders in Occlutech. The successful Private Placement of SEK 450 million, before transaction costs, confirms the confidence in Occlutech's products and market potential, with the aim of generating long-term value creation for both society and shareholders", says Marianne Dicander Alexandersson, Chairperson of Occlutech.
According to a market study, by the consulting firm Roland Berger, the developing market for interatrial shunt devices, such as Occlutech's Atrial Flow Regulator for heart failure, has an estimated market potential of about €3.9 billion in 2021 in the U.S. and EU5 (France, Germany, Italy, Spain, United Kingdom). The study also indicates that the global addressable market within structural heart disease devices is estimated at approximately €350-400 million in 2021 and is expected to grow around 10 percent annually in the next five years. Births and increased treatment adoption drive structural heart volumes while aging populations as well as lifestyle diseases, such as diabetes and overweight, cause heart failure volumes to increase.
Advisers
Carnegie Investment Bank AB (publ) acted as sole financial adviser to Occlutech. Baker McKenzie acted as the legal adviser to Occlutech as to Swedish and Swiss law.
Contacts
Sabine Bois
CEO
E-mail: sabine.bois@occlutech.com
Lars Wadell
CFO
Email: lars.wadell@occlutech.com
Phone: +46 763 20 04 34
Image Attachments
Sabine Bois CEO
Marianne Dicander Alexandersson Chairperson
Attachments
Occlutech has successfully completed a Private Placement of 450 MSEK to support growth
SOURCE: Occlutech Holding AG
View source version on accesswire.com:
https://www.accesswire.com/678813/Occlutech-has-Successfully-Completed-a-Private-Placement-of-450-MSEK-to-Support-growth
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Climate Goals Threatened by Industrialised Animal Farming, Reveals Key International Study11.11.2025 15:20:00 CET | Press release
LONDON, UK / ACCESS Newswire / November 11, 2025 / A new study in Animals highlights that industrialized animal farming is one of the most powerful - yet persistently neglected - forces driving the climate and biodiversity crises. The analysis, "The Missing Target: Why Industrialized Animal Farming Must Be at the Core of the Climate Agenda," synthesizes evidence from 47 international studies and concludes that reducing livestock production and embracing plant-based food systems is essential for meeting global climate goals. Major Insights Across global research, livestock farming contributes an estimated 12-20% of all greenhouse gas emissions annually, with the most comprehensive studies yielding the highest figures. The most modern accounting methods, which include the impacts of deforestation, bottom trawling and cooling effects from certain atmospheric pollutants, reveal that 52% of present-day global warming is attributable to animal agriculture. Animal agriculture occupies over 80
Resin Solutions Announces Commencement of up to $100 Million Global HTPB Production Expansion Initiative11.11.2025 15:00:00 CET | Press release
EXTON, PA / ACCESS Newswire / November 11, 2025 / Resin Solutions, Exton, PA, a portfolio company of Pacific Avenue Capital Partners, announced a multi-phase production capacity expansion initiative for its hydroxyl-terminated polybutadiene ("HTPB") product line, Poly bd®. Resin Solutions has begun the initial expansion phase, which includes debottlenecking initiatives and major capital investments at the company's Channelview, Texas and Ravenna, Italy facilities, which would expand existing capacity to meet expected additional demand for critical U.S. National Security Programs. In addition, the Resin Solutions Board has commenced a scoping and feasibility assessment to support additional greenfield capacity expansion in the United States and Europe. The Board of Resin Solutions, with support from Pacific Avenue Capital Partners, has authorized investment of up to $100 million to ensure Resin Solutions remains able to serve growing customer demand for HTPB in its aerospace, defense, a
MicroVision Collaborates with Leading Photonics Ecosystem to Acquire FMCW Lidar Business10.11.2025 22:05:00 CET | Press release
REDMOND, WA / ACCESS Newswire / November 10, 2025 / MicroVision, Inc. (NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions in autonomy and mobility, today announced that it had entered into an agreement to acquire the business and assets of Scantinel Photonics GmbH, a developer of 1550nm frequency-modulated continuous wave, or FMCW, lidar technology targeted for initial application in the commercial vehicle market. In connection with the acquisition, MicroVision is collaborating with certain funding and strategic partners to accelerate productization and commercial opportunities. Scantinel Photonic's core technology was developed with financial backing and key support from Zeiss Group, a German manufacturer of optical systems and optoelectronics; Scania, a Swedish commercial trucking OEM; and PhotonVentures, a deep tech venture capital firm purely focused on the key enabling technology of integrated photonics and a strategic partner of PhotonDelta, a Dutch distr
Loop Industries Executes a Multi-Year Offtake Agreement With Nike, the Global Leader in Athletic Footwear and Apparel10.11.2025 14:00:00 CET | Press release
Nike signs on as the anchor customer for the Infinite Loop™ India manufacturing facility. Multi-year offtake agreement secures supply of Twist™, Loop's branded, virgin-quality polyester resin made exclusively from textile waste. Twist™ will feature full traceability via Loop's proprietary chemical tracer technology, providing verifiable textile to textile recycled content. Infinite Loop India is a joint venture between Loop industries and Ester industries. MONTRÉAL, QUEBEC / ACCESS Newswire / November 10, 2025 / Loop Industries, Inc. (Nasdaq:LOOP) ("Loop"), a clean technology company accelerating the circular economy, today announced a multi-year offtake agreement with NIKE, Inc. ("Nike"), the global leader in athletic footwear and apparel. Under the agreement, Loop will supply Twist™, its virgin-quality circular polyester resin made exclusively from textile waste, establishing Nike as the anchor customer for the Infinite Loop™ India manufacturing facility which is being constructed in
EverC Introduces AI-powered Scam Network Intelligence to Disrupt Fraud Online10.11.2025 09:00:00 CET | Press release
The solution maps the entire scam infrastructure across e-commerce, social media, and payments marketplaces NEW YORK CITY, NY / ACCESS Newswire / November 10, 2025 / EverC, now part of G2 Risk Solutions, today announced Scam Network Intelligence, an AI-powered solution that exposes scam networks to help marketplaces detect and disrupt fraud. Scams are now the largest driver of fraud losses globally, accounting for 23% of fraudulent transactions in 2024, with losses reaching $1 trillion. To address the rise in fraud in the payments and e-commerce space, the Scam Network Intelligence solution gives marketplaces visibility into the networks behind online scams. The solution has the ability to identify and map how scammers reach and engage their victims-across ad networks, fake support portals, messaging apps, and social media networks. By identifying scam clusters early, the payments ecosystem can reduce blind spots and prevent consumer harm. "Fraud is increasingly sophisticated and flows
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom